News

Public · Published

Freedom Broker maintains Merck & Co at Hold, raises price target to $140 from $125

Freedom Broker kept its Hold rating on Merck & Co and raised its price target to $140 from $125, a 12.0% increase. The new target implies a 5.6% downside from Merck's November 2 close of $148.36.

Published:

Updated:

What happened

Freedom Broker kept its Hold rating on Merck & Co and raised its price target to $140 from $125, a 12.0% increase. The new target implies a 5.6% downside from Merck's November 2 close of $148.36.

Confirmed

Global impact / market context

A Hold rating with a target below the current share price suggests the analyst sees limited near-term upside after Merck's recent run. The higher target still signals more value than before, so investors get a mixed message rather than a clear sell signal.

Analyst inference

Other recent analyst targets on Merck range from $140 to $180, and ratings include Neutral, Overweight, Sector Perform, and Buy. Freedom Broker's $140 sits at the low end of that range, showing it is more cautious than several peers covering the same stock.

Analyst inference

What to watch

  1. Freedom Broker's $140 target compares with a November 2 close of $148.36, so watch whether Merck's shares move toward or away from that level. Confirmed
  2. Watch whether other analysts change their Merck ratings or price targets, since the recent range of $140 to $180 shows differing views on the stock. Proposed
  3. Watch Merck's future profit and revenue reports, because analyst targets and ratings often shift when company results differ from what analysts expected. Analyst inference

Evidence

  • Original source link unavailable